UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (349) 349
life sciences & biomedicine (346) 346
bcr-abl1 (333) 333
humans (291) 291
chronic myeloid leukemia (240) 240
hematology (185) 185
oncology (164) 164
fusion proteins, bcr-abl - genetics (161) 161
leukemia (141) 141
hemic and lymphatic diseases (140) 140
leukemia, myelogenous, chronic, bcr-abl positive - genetics (133) 133
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (114) 114
male (106) 106
female (102) 102
imatinib (85) 85
middle aged (84) 84
adult (83) 83
protein kinase inhibitors - therapeutic use (83) 83
philadelphia chromosome (78) 78
tyrosine (75) 75
aged (70) 70
cml (66) 66
mutation (65) 65
antineoplastic agents - therapeutic use (62) 62
bcr‐abl1 (62) 62
imatinib mesylate (61) 61
tyrosine kinase inhibitors (61) 61
analysis (57) 57
genetic aspects (55) 55
fusion proteins, bcr-abl - metabolism (52) 52
tyrosine kinase inhibitor (51) 51
cancer (50) 50
leukemia, myelogenous, chronic, bcr-abl positive - pathology (50) 50
chronic myeloid leukaemia (49) 49
nilotinib (46) 46
adolescent (43) 43
animals (42) 42
dasatinib (42) 42
pyrimidines - therapeutic use (42) 42
chronic myelogenous leukemia (41) 41
young adult (41) 41
care and treatment (40) 40
kinases (39) 39
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (39) 39
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (39) 39
patients (37) 37
research (37) 37
treatment outcome (37) 37
polymerase chain reaction (35) 35
precursor cell lymphoblastic leukemia-lymphoma - genetics (35) 35
prognosis (35) 35
protein-tyrosine kinase (35) 35
myeloid leukemia (34) 34
piperazines - therapeutic use (34) 34
hematology, oncology and palliative medicine (33) 33
acute lymphoblastic leukemia (32) 32
stem cells (32) 32
medicine & public health (31) 31
benzamides (30) 30
drug resistance, neoplasm - genetics (30) 30
aged, 80 and over (28) 28
bcr/abl1 (28) 28
pathology (28) 28
cell biology (27) 27
child (26) 26
drug resistance (25) 25
imatinib mesylate - therapeutic use (25) 25
minimal residual disease (24) 24
neoplasms. tumors. oncology. including cancer and carcinogens (24) 24
antineoplastic agents (23) 23
bone marrow (23) 23
chromosomes (23) 23
drug resistance, neoplasm (23) 23
fusion proteins, bcr-abl - antagonists & inhibitors (23) 23
gene expression (23) 23
protein-tyrosine kinases - antagonists & inhibitors (23) 23
biochemistry & molecular biology (22) 22
original (22) 22
protein kinase inhibitors - pharmacology (22) 22
review (22) 22
rna, messenger - genetics (22) 22
mice (21) 21
genetics & heredity (20) 20
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (20) 20
acute lymphatic leukemia (19) 19
acute lymphocytic leukemia (19) 19
development and progression (19) 19
flow cytometry (19) 19
genes (19) 19
in situ hybridization, fluorescence (19) 19
protein kinase inhibitors - adverse effects (19) 19
antimitotic agents (18) 18
diagnosis (18) 18
health aspects (18) 18
original article (18) 18
proteins (18) 18
antineoplastic agents - pharmacology (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
chemotherapy (17) 17
child, preschool (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (494) 494
French (7) 7
Chinese (6) 6
Portuguese (6) 6
Polish (4) 4
Czech (3) 3
Spanish (3) 3
German (2) 2
Slovenian (2) 2
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of haematology, ISSN 0007-1048, 01/2015, Volume 168, Issue 1, pp. 69 - 81
Summary Bosutinib is an oral, dual SRC/ABL1 tyrosine kinase inhibitor for resistant/intolerant chronic myeloid leukaemia (CML). We assessed the efficacy and... 
BCR‐ABL1 | CML | tyrosine kinase inhibitor | bosutinib | chronic myeloid leukaemia | Chronic myeloid leukaemia | Tyrosine kinase inhibitor | Bosutinib | BCR-ABL1 | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus | Haematological Malignancy
Journal Article
Frontiers in oncology, ISSN 2234-943X, 03/2014, Volume 4, pp. 54 - 54
The t(9;22)(q34;q11) or Philadelphia chromosome creates a BCR-ABL1 fusion gene encoding for a chimeric BCR-ABL1 protein. It is present in 3-4% of pediatric... 
Chemotherapy | Acute lymphoblastic leukemia | Tyrosine kinase inhibition | BCR-ABL1 | Hematopoietic stem-cell transplantation | Hematopoietic Stem Cell Transplantation | Tyrosine Kinase Inhibition | chemotherapy | Acute Lymphoblastic Leukemia
Journal Article
International journal of hematology, ISSN 1865-3774, 09/2017, Volume 107, Issue 2, pp. 185 - 193
Journal Article
Nature reviews. Cancer, ISSN 1474-1768, 08/2010, Volume 10, Issue 9, pp. 618 - 629
Journal Article